PAR-25-057-Full-Announcement.html

This document is a Notice of Funding Opportunity (NOFO) for the NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required). The NOFO is solicitation number PAR-25-057 and is funded under CFDA 93.121 Oral Diseases and Disorders Research.

The purpose of this funding opportunity is to support UG3/UH3 phased, cooperative agreement research applications to plan and implement clinical trials within the mission of the National Institute of Dental and Craniofacial Research (NIDCR). Eligible applicant types include small businesses, non-profits, tribal governments, state/local governments, and higher education institutions. The NOFO provides details on the funding instruments, award amounts, project periods, and application and review process. Key dates include the optional letter of intent due on XX/XX/XXXX and the application due date of XX/XX/XXXX. The National Institutes of Health is the federal agency administering this opportunity.